yego.me
💡 Stop wasting time. Read Youtube instead of watch. Download Chrome Extension

Ebola 101 | National Geographic


2m read
·Nov 11, 2024

Blood clots begin to form, internal organs begin to fail, and in a matter of days, the body hemorrhages and dies. Terrors all caused by a nightmare come to life.

Ebola is a rare but extremely dangerous disease. It's classified as one of the most lethal diseases on the planet with a fatality rate of up to 90%.

Ebola is caused by six species of virus, with four known to cause sickness in humans, and each is named after the locations of their outbreaks. The first known species was Zaire ebolavirus, discovered in 1976 near Zaire's Ebola River, a river fated to become the namesake of all Ebola viruses.

Like all viruses, Ebola viruses infect and feed off of their hosts starting on a microscopic level. The viruses, which are string-like structures, contain genetic information in the form of ribonucleic acid, or RNA.

Encasing the RNA are layers of proteins. The proteins on the outermost layer are highly versatile, capable of changing shape and binding to different types of cells within a host. When binding occurs, the Ebola virus fuses with a host cell, allowing the virus' RNA to infiltrate the cell and to replicate the virus from within.

This infection quickly spreads to countless cells throughout the body, resulting in some of the most terrifying symptoms known to man. Within eight to 10 days, those infected by the Ebola virus may experience symptoms drastically ranging in severity from fevers to diarrhea and vomiting to internal and external bleeding, often from the eyes.

While outbreaks have been caused by multiple species of Ebola virus, the strain with the highest fatality rate was the first to be discovered, Zaire ebolavirus. In 2014, it caused the most severe outbreak in history, sweeping through western Africa and resulting in over 11,000 deaths, more than all earlier Ebola outbreaks put together.

At this point, no cure for Ebola exists. Plus, the communities most likely to be affected do not have sufficient access to healthcare. In the meantime, international efforts are being made to develop and test vaccines that could potentially stop the disease once and for all.

(somber music)

More Articles

View All
My Thoughts On The Millionaire Tax
What’s up, Graham? It’s Guys here. So, I want to talk about something that I’ve seen come up a lot lately, and that would be a proposed wealth tax. Now, initially, this is not a topic I was planning to address, but because we talk all things personal fina…
Example plotting corners of rectangle
The four corners of a rectangle are located at the points (11, 7), (11, 0), (2, 0), and (2, 7). Plot the four corners of the rectangle on the coordinate plane below, and they have these dots, and we can actually move these around for the four corners of o…
FIRST Photo on the INTERNET ... and other things too.
Hey, Vsauce. Michael here. And this week I am in San Francisco. I just flew in a couple of days ago, so I’ve been busy traveling, but new episodes of regular shows like IMG! and DONG are coming soon. But in the meantime, rather than post nothing, I figur…
The Psychology of Game of Thrones | StarTalk
So Travis, are you there? I am here. I’ve been summoned. NEIL DEGRASSE TYSON (VOICEOVER): Hey! [laughter] [cheering and applause] So you’re a professional psychologist but also a fan of “Game of Thrones”? Oh, yes. I am a psychology professor, a big nerd…
Photos: When Food Prices Go Up, What Happens? | Nat Geo Live
We are now 7.3 billion fellow human beings, on the only place we can live, and in the next twenty-five years, we’re going to be 9 billion fellow human beings with no other place to go. I went to Egypt. Right before the landscape of the Great Pyramids of …
Michael Seibel - How to Plan an MVP
My name is Michael. Uh, I work here at Y Combinator. I helped run the accelerator. Uh, before that, I did two YC startups—one in 2007 and one in 2012. Today, I’m going to talk to you about a minimum viable product, so MVP. We always yell at founders to n…